Home / Science / Dog's Dementia Study Unlocks Human Health Secrets
Dog's Dementia Study Unlocks Human Health Secrets
8 Jun
Summary
- Ralph's brain scans showed shrinkage and fluid buildup due to dementia.
- Studying canine dementia may reveal insights into human Alzheimer's.
- Rapamycin drug showed promise in reducing inflammation in dog brains.
In 2025, Ralph the dog was diagnosed with dementia, prompting his enrollment in the Dog Aging Project. This extensive collaboration between pet owners, veterinarians, and scientists aims to study aging in dogs, with over 50,000 participants to date. Researchers, like neuropathologist Dr. Dirk Keene, believe studying canine dementia offers unique insights into human diseases such as Alzheimer's.
Brain comparisons have revealed striking structural similarities between dog and human brains, particularly in how dementia causes shrinkage and increased fluid-filled cavities. Ralph underwent cognitive tests and an MRI scan, which clearly indicated his cognitive impairment and brain changes.
Following Ralph's passing in December 2025, a pilot study examined the drug rapamycin. In this study, dogs treated with rapamycin showed fewer inflammatory microglial cells in their brains compared to those given a placebo. The Rowe family expressed pride that Ralph's contribution to science provided him with added purpose, potentially aiding future treatments for dementia.
